magnifying glass
Jeffrey WagerA+

Jeffrey Wager

Chairman & Chief Executive Officer at EnBiotix

Between 2011-2017, co-creator and BOD observer to Grupo Biotoscana SL, a Latin American specialty pharma roll-up financed by Advent International and Essex Woodlands Healthcare Ventures, focused on cancer, infectious and rare diseases, leading to its USD 1 billion 2017 IPO on sales of ~$240M and 600 staff in 10 LatAm markets.From 2006 – 2010, formed and led Artisan Pharma, Inc. as its founding CEO, raising $53M, building the entire team and implementing a 750 patient, 17 country Phase 2b/3 study ultimately leading to Artisan’s acquisition by Asahi Kasei Pharma Corporation (Japan) in 2011. In 2000, formed Apeiron Partners, a FINRA-registered life sciences investment bank focused on corporate spin-outs, M+A, corporate venture capital and principal investments. In the process, successfully completed six spin-outs, including Targacept, Inc. (NASD:TRGT), Artisan Pharma (from Asahi Kasei), Biocritica ($120M annual revenue Xigris® franchise from Eli Lilly) and KBI BioPharma (acquired by JSR Corporation (Japan)). Between 2003 and 2006, advised on the establishment and investment of Z-Cube s.r.l., the €60M corporate venture fund of the Zambon Group, a privately-held Italian pharmaceutical company. Between 1995-2000, Dr. Wager was with Medical Science Partners, a Harvard-founded VC fund focused on forming spin-outs from the Harvard medical system, including deCODE, ICAgen, Inspire, Oravax (subsequently Acambis), ZYCOS, Inc. and Diatide, amongst others. Dr. Wager began his career with a life sciences unit of the Bank of Tokyo, where he led business development, responsible for helping Japanese pharmaceutical clients establish overseas affiliates, design and conduct overseas clinical development and structure strategic alliances. Dr. Wager is also a co-founder and Chairman of Proterris, Inc., a P2/3 clinical-stage firm focused on therapeutic uses of low-dose gaseous and small molecule carbon monoxide for transplant, fibrosis, and oncology indications. Dr. Wager earned his MD from Rush Medical College and his MBA from the University of Chicago.Read More

Export

Last Update

4/27/2022 9:25 AM
Get Email Address

Direct Phone

(***) ***-****
Get Direct Phone
Get Mobile Number

HQ Phone

(508) 400-1856

Company

EnBiotix

Location

197 W Springfield St, Boston, Massachusetts, 02118, United States

Jeffrey Wager Current Workplace

Location

197 W Springfield St, Boston, Massachusetts, 02118, United States

Description

EnBiotix is an engineered antibiotics company deploying novel systems and synthetic biology technologies developed by Prof. James J. Collins, the Termeer Professor of Medical Engineering & Science Professor, Department of Biological Engineering, Mass...
Read More

Jeffrey Wager Work Experience and Education

Board Memberships & Affiliations

Executive Chairman

Proterris

2011-2022

To The Establishment & Investment Advisor

Z-Cube Srl

2002-

Education

University of Chicago

MBA

University of Chicago
Rush Medical College

MD

Rush Medical College

Org Chart - EnBiotix

Profile Picture

Chairman & Chief Executive Officer

PhonePhoneEmailEmail
Profile Picture

PhonePhoneEmailEmail
Profile Picture

PhonePhoneEmailEmail
Profile Picture

PhonePhoneEmailEmail
Profile Picture

PhonePhoneEmailEmail

Recent News About Jeffrey Wager

Web References
Scoops
Intent

Jeffrey D. Wager 197 W Springfield Street Boston MA MASSACHUSETTS 02118 Executive Officer Director

Polyphor to Inform about the Financing of its <b>Merger</b> Partner EnBiotix | BioSpace

"We are very pleased that we have now completed this last and important step catalyzing the closing of the business combination of EnBiotix and Polyph...

EnBiotix, Inc. Closes $11M Pre-<b>Merger</b> Financing | Financial Post

Jeffrey D. Wager , M.D., Chairman and CEO of EnBiotix , commented, "It is very motivating for all of us at EnBiotix to secure this financing from such...

People Similar to Jeffrey Wager

Top 3 Recommended Profiles

Match relevance is based on profile similarity to job title and locationjob title and industrypeople with the same last name
Profile Picture
Robert Lanier

Chairman & Chief Executive Officer

PhoneEmail
See Profile
Profile Picture
Jeffrey Witherell

Chairman & Chief Executive Officer

PhoneEmail
See Profile
Profile Picture
Leigh Wager

Supervisor, Client Service & Commer...

PhoneEmail
See Profile

People Also Search For:

See more

Frequently Asked Questions regarding Jeffrey Wager

What company does Jeffrey Wager work for?

Jeffrey Wager works for EnBiotix

What is Jeffrey Wager’s role in EnBiotix?

Jeffrey Wager’s role in EnBiotix is Chairman & Chief Executive Officer

What is Jeffrey Wager’s email address?

Jeffrey Wager’s email address is j***@enbiotix.com

What is Jeffrey Wager’s business email address?

Jeffrey Wager’s business email address is j***@enbiotix.com

What is Jeffrey Wager’s direct phone number?

Jeffrey Wager’s direct phone number is (***) ***-****

What is Jeffrey Wager’s HQ phone number?

Jeffrey Wager’s HQ phone number is (508) 400-1856

What is Jeffrey Wager’s latest education?

Jeffrey Wager’s latest education in MBA at University of Chicago

Which industry does Jeffrey Wager work in?

Jeffrey Wager works in the industry of Pharmaceuticals, Healthcare, Biotechnology.... See More

Who are Jeffrey Wager’s peers at other companies?

Jeffrey Wager’s peers at other companies are Robert Lanier, Andrew Spaventa, Richard Mueller, Elena Shembel, David Simmons.